Twelve months after revaccination, antibody levels declined but remained significantly higher than baseline in patients with CLL.

and one pneumococcal polysaccharide vaccine (PPSV23) for protection against pneumococcal disease. A serotype is a variation of a bacterium or virus. The immune system may react differently to ...

The CDC’s ACIP updated guidance on pneumococcal vaccination, recommending a single dose of PCV for all adults aged 50 years and older.

Participants were randomized to receive a single dose of either one of three lots of CAPVAXIVE or PPSV23 (pneumococcal 23-valent polysaccharide vaccine). Results from the study include ...

and STRIDE-10 (NCT05569954), which compared Capvaxive to PPSV23 (pneumococcal vaccine, polyvalent [23-valent]) in adults 50 years of age and older who had not previously received a pneumococcal ...

Some assume pneumonia is an inevitable consequence of ageing, while others may not realise they are at risk, says infectious ...